← Back to Search

Stent Graft System

NEXUS Stent Graft for Aortic Disease (TRIOMPHE Trial)

N/A
Recruiting
Research Sponsored by Endospan Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intramural hematoma with specific conditions
Proximal/ascending native or previously implanted surgical graft landing zone of appropriate diameter
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

TRIOMPHE Trial Summary

This trial is testing a new stent graft system for treating aortic arch lesions. The stent graft will have a proximal landing zone in the ascending aorta and a brachiocephalic trunk native landing zone.

Who is the study for?
This trial is for adults over 18 with certain aortic conditions like aneurysms or dissections, who are high-risk candidates for open surgery. They must have suitable anatomy for the NEXUS Stent Graft System and be able to follow study procedures. Pregnant individuals, those with recent major surgeries or heart attacks, severe infections, or known allergies to device materials cannot participate.Check my eligibility
What is being tested?
The NEXUS Aortic Arch Clinical Study tests the safety and effectiveness of the NEXUS Aortic Stent Graft System in treating thoracic aortic lesions involving the arch. It's non-randomized and multi-center, focusing on patients with specific anatomical features suitable for this elective endovascular repair procedure.See study design
What are the potential side effects?
Potential side effects may include complications related to stent grafts such as movement of the stent after placement, blockage or narrowing at the site where it's implanted (stenosis), injury to access vessels during insertion, bleeding due to anticoagulants used during implantation, and general risks associated with endovascular procedures.

TRIOMPHE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a blood clot within the walls of my blood vessels.
Select...
My heart surgery area is the right size for a new procedure.
Select...
I have an aneurysm with specific conditions.
Select...
I have a penetrating ulcer in my aorta.
Select...
My blood vessels are suitable for certain surgical procedures.
Select...
I have a long-term tear in my blood vessel wall.

TRIOMPHE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Failure
Device Technical Failure

TRIOMPHE Trial Design

3Treatment groups
Experimental Treatment
Group I: Penetrating Aortic Ulcer and/or Intramural HematomaExperimental Treatment1 Intervention
Group II: Chronic DissectionExperimental Treatment1 Intervention
Group III: AneurysmExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Endospan Ltd.Lead Sponsor
5 Previous Clinical Trials
86 Total Patients Enrolled
2 Trials studying Aortic Aneurysm
48 Patients Enrolled for Aortic Aneurysm

Media Library

NEXUS Aortic Stent Graft System (Stent Graft System) Clinical Trial Eligibility Overview. Trial Name: NCT04471909 — N/A
Aortic Aneurysm Research Study Groups: Chronic Dissection, Penetrating Aortic Ulcer and/or Intramural Hematoma, Aneurysm
Aortic Aneurysm Clinical Trial 2023: NEXUS Aortic Stent Graft System Highlights & Side Effects. Trial Name: NCT04471909 — N/A
NEXUS Aortic Stent Graft System (Stent Graft System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04471909 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being actively sought for this clinical experiment?

"According to clinicaltrials.gov, this research study is currently recruiting participants and has been since October 20th 2020. The trial was last updated on June 13th 2022."

Answered by AI

How many participants is the trial allowing to enroll?

"The sponsor for this research, Endospan Ltd., is recruiting 100 participants that match their criteria from two clinics - University of Alabama Birmingham and Baylor Scott and White."

Answered by AI

How many healthcare facilities are conducting this experiment?

"The trial is presently recruiting from 21 different medical centres. These include Birmingham, Plano, and Ann Arbor in addition to other places around the nation. To minimize transportation needs for patients wishing to join this experiment, it is highly recommended that they select a nearby clinic."

Answered by AI
~7 spots leftby Aug 2024